Transcatheter aortic valve replacement outcomes in solid organ transplant recipients.
Megan E CampanyArchis R BhandarkarMohamad BydonBritton B DonatoKristen A Sell-DottinPublished in: Journal of cardiac surgery (2022)
SOT recipients have no increased risk of mortality or periprocedural complications when undergoing TAVR. Though the rate of thromboembolic events was higher in SOT recipients, observation size was small (n = 27 TAVR, n = 4 TAVR + SOT) thus external validity is limited. Based on these data, transplant recipients experience no difference in outcomes following TAVR as compared to patients without a history of organ transplant.
Keyphrases
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve
- ejection fraction
- end stage renal disease
- newly diagnosed
- risk factors
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- percutaneous coronary intervention
- atrial fibrillation
- patient reported outcomes
- coronary artery disease
- machine learning
- big data
- metabolic syndrome
- type diabetes
- adipose tissue
- venous thromboembolism
- insulin resistance
- weight loss
- skeletal muscle
- catheter ablation